In the last 12 months, insiders at KalVista Pharmaceuticals, Inc. ($KALV) filed 473 transactions with the SEC: 33 open-market purchases totaling $19,435,088 and 108 sales totaling $15,248,312. Net insider sentiment: net buying.
KalVista Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Venrock Healthcare Capital Partners III, L.P. (Not found) — 25 transactions totaling $12,078,205
- Venrock Healthcare Capital Partners III, L.P. (TenPercentOwner) — 13 transactions totaling $11,048,031
- Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER) — 84 transactions totaling $2,748,812
- Crockett Thomas Andrew (CEO) — 33 transactions totaling $2,139,681
- Yea Christopher (CHIEF DEVELOPMENT OFFICER) — 81 transactions totaling $1,974,128
View all SEC Filings for KalVista Pharmaceuticals, Inc. (KALV).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | Venrock Healthcare Capital Partners III, L.P. | Not found | S | Common Stock | 160 | $17.53 | 5,129,340.0000 | 53,883,681 | 0.00% | 0.00% |
| March 26, 2026 | Venrock Healthcare Capital Partners III, L.P. | Not found | S | Common Stock | 15417 | $18.82 | 5,092,537.0000 | 53,883,681 | 0.30% | 0.03% |
| March 26, 2026 | Venrock Healthcare Capital Partners III, L.P. | Not found | S | Common Stock | 3183 | $19.12 | 5,089,354.0000 | 53,883,681 | 0.06% | 0.01% |
| March 26, 2026 | Venrock Healthcare Capital Partners III, L.P. | Not found | S | Common Stock | 21386 | $17.76 | 5,107,954.0000 | 53,883,681 | 0.42% | 0.04% |
| March 25, 2026 | Venrock Healthcare Capital Partners III, L.P. | Not found | S | Common Stock | 174485 | $16.95 | 5,129,500.0000 | 53,883,681 | 3.29% | 0.32% |
| March 9, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 6693 | $16.08 | 451,815.0000 | 53,883,681 | 1.46% | 0.01% |
| March 6, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 125,001.0000 | 53,883,681 | 11.11% | 0.03% |
| March 6, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 458,508.0000 | 53,883,681 | 3.53% | 0.03% |
| Feb. 21, 2026 | Piekos Brian | Chief Financial Officer | M | Common Stock | 5000 | $0.00 | 15,529.0000 | 53,883,681 | 47.49% | 0.01% |
| Feb. 21, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6250 | $0.00 | 139,337.0000 | 53,883,681 | 4.70% | 0.01% |
| Feb. 22, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 144,337.0000 | 53,883,681 | 3.59% | 0.01% |
| Feb. 23, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 5354 | $15.57 | 138,983.0000 | 53,883,681 | 3.71% | 0.01% |
| Feb. 21, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 75,000.0000 | 53,883,681 | 7.69% | 0.01% |
| Feb. 22, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 45,000.0000 | 53,883,681 | 10.00% | 0.01% |
| Feb. 21, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 23250 | $0.00 | 452,917.0000 | 53,883,681 | 5.41% | 0.04% |
| Feb. 23, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10034 | $15.57 | 442,883.0000 | 53,883,681 | 2.22% | 0.02% |
| Feb. 21, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3750 | $0.00 | 227,923.0000 | 53,883,681 | 1.67% | 0.01% |
| Feb. 22, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3125 | $0.00 | 231,048.0000 | 53,883,681 | 1.37% | 0.01% |
| Feb. 23, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 4347 | $15.57 | 226,701.0000 | 53,883,681 | 1.88% | 0.01% |
| Feb. 21, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3750 | $0.00 | 45,000.0000 | 53,883,681 | 7.69% | 0.01% |
| Feb. 22, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3125 | $0.00 | 28,125.0000 | 53,883,681 | 10.00% | 0.01% |
| Feb. 21, 2026 | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 6250 | $0.00 | 45,978.0000 | 53,883,681 | 15.73% | 0.01% |
| Feb. 22, 2026 | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 5000 | $0.00 | 50,978.0000 | 53,883,681 | 10.87% | 0.01% |
| Feb. 23, 2026 | Sweeny Nicole | Chief Commercial Officer | S | Common Stock | 3975 | $15.57 | 47,003.0000 | 53,883,681 | 7.80% | 0.01% |
| Feb. 21, 2026 | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 6250 | $0.00 | 75,000.0000 | 53,883,681 | 7.69% | 0.01% |
| Feb. 22, 2026 | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 5000 | $0.00 | 45,000.0000 | 53,883,681 | 10.00% | 0.01% |
| Feb. 23, 2026 | Piekos Brian | Chief Financial Officer | S | Common Stock | 1767 | $15.57 | 13,762.0000 | 53,883,681 | 11.38% | 0.00% |
| Feb. 21, 2026 | Piekos Brian | Chief Financial Officer | M | Restricted Stock Unit | 5000 | $0.00 | 60,000.0000 | 53,883,681 | 7.69% | 0.01% |
| Feb. 21, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 23250 | $0.00 | 279,000.0000 | 53,883,681 | 7.69% | 0.04% |
| Feb. 17, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 2419 | $0.00 | 134,250.0000 | 53,883,681 | 1.83% | 0.00% |
| Feb. 17, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 2,419.0000 | 53,883,681 | 50.00% | 0.00% |
| Feb. 17, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 1774 | $0.00 | 225,282.0000 | 53,883,681 | 0.79% | 0.00% |
| Feb. 18, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 1163 | $15.00 | 133,087.0000 | 53,883,681 | 0.87% | 0.00% |
| Feb. 17, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 1,774.0000 | 53,883,681 | 50.00% | 0.00% |
| Feb. 17, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 2419 | $0.00 | 430,705.0000 | 53,883,681 | 0.56% | 0.00% |
| Feb. 18, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1038 | $15.00 | 429,667.0000 | 53,883,681 | 0.24% | 0.00% |
| Feb. 18, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 1109 | $15.00 | 224,173.0000 | 53,883,681 | 0.49% | 0.00% |
| Feb. 17, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 2,419.0000 | 53,883,681 | 50.00% | 0.00% |
| Feb. 12, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 3354 | $15.70 | 428,286.0000 | 53,883,681 | 0.78% | 0.01% |
| Feb. 11, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 7120 | $0.00 | 431,640.0000 | 53,883,681 | 1.68% | 0.01% |
| Feb. 11, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 7120 | $0.00 | 99,680.0000 | 53,883,681 | 6.67% | 0.01% |
| Jan. 16, 2026 | Sweeny Nicole | Chief Commercial Officer | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 53,883,681 | 9999.99% | 0.19% |
| Jan. 16, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 325000 | $0.00 | 325,000.0000 | 53,883,681 | 9999.99% | 0.60% |
| Jan. 16, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 53,883,681 | 9999.99% | 0.19% |
| Jan. 16, 2026 | Piekos Brian | Chief Financial Officer | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 53,883,681 | 9999.99% | 0.19% |
| Jan. 16, 2026 | Arif Bilal | Chief Operations Officer | A | Restricted Stock Unit | 49000 | $0.00 | 49,000.0000 | 53,883,681 | 9999.99% | 0.09% |
| Dec. 8, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7294 | $16.51 | 424,520.0000 | 53,883,681 | 1.69% | 0.01% |
| Dec. 6, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 431,814.0000 | 53,883,681 | 3.75% | 0.03% |
| Dec. 6, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 140,626.0000 | 53,883,681 | 10.00% | 0.03% |
| Nov. 24, 2025 | Sweeny Nicole | Chief Commercial Officer | S | Common Stock | 3813 | $13.45 | 39,728.0000 | 53,883,681 | 8.76% | 0.01% |
| Nov. 21, 2025 | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 6250 | $0.00 | 38,541.0000 | 53,883,681 | 19.36% | 0.01% |
| Nov. 22, 2025 | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 5000 | $0.00 | 43,541.0000 | 53,883,681 | 12.97% | 0.01% |
| Nov. 22, 2025 | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 5000 | $0.00 | 50,000.0000 | 53,883,681 | 9.09% | 0.01% |
| Nov. 21, 2025 | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 6250 | $0.00 | 81,250.0000 | 53,883,681 | 7.14% | 0.01% |
| Nov. 21, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3750 | $0.00 | 48,750.0000 | 53,883,681 | 7.14% | 0.01% |
| Nov. 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3125 | $0.00 | 227,839.0000 | 53,883,681 | 1.39% | 0.01% |
| Nov. 24, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 4331 | $13.45 | 223,508.0000 | 53,883,681 | 1.90% | 0.01% |
| Nov. 21, 2025 | Piekos Brian | Chief Financial Officer | M | Common Stock | 15000 | $0.00 | 15,000.0000 | 53,883,681 | 9999.99% | 0.03% |
| Nov. 21, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3750 | $0.00 | 224,714.0000 | 53,883,681 | 1.70% | 0.01% |
| Nov. 21, 2025 | Piekos Brian | Chief Financial Officer | M | Restricted Stock Unit | 15000 | $0.00 | 65,000.0000 | 53,883,681 | 18.75% | 0.03% |
| Nov. 24, 2025 | Piekos Brian | Chief Financial Officer | S | Common Stock | 4471 | $13.45 | 10,529.0000 | 53,883,681 | 29.81% | 0.01% |
| Nov. 21, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 23250 | $0.00 | 302,250.0000 | 53,883,681 | 7.14% | 0.04% |
| Nov. 24, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10940 | $13.45 | 416,189.0000 | 53,883,681 | 2.56% | 0.02% |
| Nov. 21, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 23250 | $0.00 | 427,129.0000 | 53,883,681 | 5.76% | 0.04% |
| Nov. 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 50,000.0000 | 53,883,681 | 9.09% | 0.01% |
| Nov. 21, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 81,250.0000 | 53,883,681 | 7.14% | 0.01% |
| Nov. 24, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 5296 | $13.45 | 131,831.0000 | 53,883,681 | 3.86% | 0.01% |
| Nov. 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 137,127.0000 | 53,883,681 | 3.78% | 0.01% |
| Nov. 21, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6250 | $0.00 | 132,127.0000 | 53,883,681 | 4.97% | 0.01% |
| Nov. 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3125 | $0.00 | 31,250.0000 | 53,883,681 | 9.09% | 0.01% |
| Nov. 20, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 87390 | $0.00 | 220,964.0000 | 53,883,681 | 65.42% | 0.16% |
| Nov. 20, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Employee Stock Option (Right to Buy) | 87390 | $0.00 | 0.0000 | 53,883,681 | 100.00% | 0.16% |
| Nov. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 4,838.0000 | 53,883,681 | 33.33% | 0.00% |
| Nov. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 0.0000 | 53,883,681 | 100.00% | 0.01% |
| Nov. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 2431 | $0.00 | 0.0000 | 53,883,681 | 100.00% | 0.00% |
| Nov. 18, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 3075 | $14.48 | 125,877.0000 | 53,883,681 | 2.38% | 0.01% |
| Nov. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 4205 | $0.00 | 136,257.0000 | 53,883,681 | 3.18% | 0.01% |
| Nov. 18, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 2683 | $14.48 | 133,574.0000 | 53,883,681 | 1.97% | 0.00% |
| Nov. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 3,548.0000 | 53,883,681 | 33.33% | 0.00% |
| Nov. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6447 | $0.00 | 128,952.0000 | 53,883,681 | 5.26% | 0.01% |
| Nov. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 9364 | $0.00 | 408,345.0000 | 53,883,681 | 2.35% | 0.02% |
| Nov. 18, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4466 | $14.48 | 403,879.0000 | 53,883,681 | 1.09% | 0.01% |
| Nov. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 4,838.0000 | 53,883,681 | 33.33% | 0.00% |
| Nov. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6945 | $0.00 | 0.0000 | 53,883,681 | 100.00% | 0.01% |
| Nov. 12, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 3328 | $11.55 | 398,981.0000 | 53,883,681 | 0.83% | 0.01% |
| Nov. 11, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 7120 | $0.00 | 106,800.0000 | 53,883,681 | 6.25% | 0.01% |
| Nov. 11, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 7120 | $0.00 | 402,309.0000 | 53,883,681 | 1.80% | 0.01% |
| Oct. 8, 2025 | Arif Bilal | Chief Operations Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 53,883,681 | 9999.99% | 0.19% |
| Oct. 1, 2025 | Sensenig Bethany | Not found | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 53,883,681 | 9999.99% | 0.08% |
| Oct. 1, 2025 | Unkart Edward W | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 53,883,681 | 9999.99% | 0.06% |
| Oct. 1, 2025 | Fairey William | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 53,883,681 | 9999.99% | 0.06% |
| Oct. 1, 2025 | Treanor Patrick | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 53,883,681 | 9999.99% | 0.06% |
| Oct. 1, 2025 | Stuart Nancy | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 53,883,681 | 9999.99% | 0.06% |
| Oct. 1, 2025 | Pereira Brian JG | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 53,883,681 | 9999.99% | 0.06% |
| Sept. 6, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 156,251.0000 | 49,652,878 | 9.09% | 0.03% |
| Sept. 6, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 402,483.0000 | 49,652,878 | 4.04% | 0.03% |
| Sept. 8, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7294 | $15.84 | 395,189.0000 | 49,652,878 | 1.81% | 0.01% |
| Aug. 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 55,000.0000 | 49,652,878 | 8.33% | 0.01% |
| Aug. 22, 2025 | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 5000 | $0.00 | 55,000.0000 | 49,652,878 | 8.33% | 0.01% |
| Aug. 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3125 | $0.00 | 134,006.0000 | 49,652,878 | 2.39% | 0.01% |
| Aug. 25, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 1954 | $13.42 | 132,052.0000 | 49,652,878 | 1.46% | 0.00% |
| Aug. 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3125 | $0.00 | 34,375.0000 | 49,652,878 | 8.33% | 0.01% |
| Aug. 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 124,841.0000 | 49,652,878 | 4.17% | 0.01% |
| Aug. 25, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2336 | $13.42 | 122,505.0000 | 49,652,878 | 1.87% | 0.00% |
| Aug. 22, 2025 | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 5000 | $0.00 | 33,771.0000 | 49,652,878 | 17.38% | 0.01% |
| Aug. 25, 2025 | Sweeny Nicole | Chief Commercial Officer | S | Common Stock | 1480 | $13.42 | 32,291.0000 | 49,652,878 | 4.38% | 0.00% |
| Aug. 21, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 87,500.0000 | 49,652,878 | 6.67% | 0.01% |
| Aug. 21, 2025 | Sweeny Nicole | Chief Commercial Officer | M | Common Stock | 6250 | $0.00 | 30,635.0000 | 49,652,878 | 25.63% | 0.01% |
| Aug. 22, 2025 | Sweeny Nicole | Chief Commercial Officer | S | Common Stock | 1864 | $13.22 | 28,771.0000 | 49,652,878 | 6.08% | 0.00% |
| Aug. 21, 2025 | Sweeny Nicole | Chief Commercial Officer | M | Restricted Stock Unit | 6250 | $0.00 | 87,500.0000 | 49,652,878 | 6.67% | 0.01% |
| Aug. 21, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3750 | $0.00 | 133,243.0000 | 49,652,878 | 2.90% | 0.01% |
| Aug. 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 2362 | $13.22 | 130,881.0000 | 49,652,878 | 1.77% | 0.00% |
| Aug. 21, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3750 | $0.00 | 52,500.0000 | 49,652,878 | 6.67% | 0.01% |
| Aug. 21, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 23250 | $0.00 | 397,798.0000 | 49,652,878 | 6.21% | 0.05% |
| Aug. 22, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10940 | $13.22 | 386,858.0000 | 49,652,878 | 2.75% | 0.02% |
| Aug. 21, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 23250 | $0.00 | 325,500.0000 | 49,652,878 | 6.67% | 0.05% |
| Aug. 21, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6250 | $0.00 | 122,783.0000 | 49,652,878 | 5.36% | 0.01% |
| Aug. 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2942 | $13.22 | 119,841.0000 | 49,652,878 | 2.40% | 0.01% |
| Aug. 18, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2939 | $13.19 | 116,533.0000 | 49,652,878 | 2.46% | 0.01% |
| Aug. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6446 | $0.00 | 119,472.0000 | 49,652,878 | 5.70% | 0.01% |
| Aug. 18, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 2649 | $13.19 | 129,493.0000 | 49,652,878 | 2.00% | 0.01% |
| Aug. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1773 | $0.00 | 5,322.0000 | 49,652,878 | 24.99% | 0.00% |
| Aug. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 2430 | $0.00 | 2,431.0000 | 49,652,878 | 49.99% | 0.00% |
| Aug. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6944 | $0.00 | 6,945.0000 | 49,652,878 | 50.00% | 0.01% |
| Aug. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2418 | $0.00 | 7,257.0000 | 49,652,878 | 24.99% | 0.00% |
| Aug. 18, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4409 | $13.19 | 374,548.0000 | 49,652,878 | 1.16% | 0.01% |
| Aug. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 4203 | $0.00 | 132,142.0000 | 49,652,878 | 3.29% | 0.01% |
| Aug. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 9362 | $0.00 | 378,957.0000 | 49,652,878 | 2.53% | 0.02% |
| Aug. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 4,028.0000 | 49,652,878 | 50.00% | 0.01% |
| Aug. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2418 | $0.00 | 7,257.0000 | 49,652,878 | 24.99% | 0.00% |
| Aug. 11, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 113920 | $0.00 | 113,920.0000 | 49,652,878 | 9999.99% | 0.23% |
| Aug. 11, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option | 113920 | $0.00 | 113,920.0000 | 49,652,878 | 9999.99% | 0.23% |
| July 9, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 30250 | $15.69 | 127,939.0000 | 49,652,878 | 19.12% | 0.06% |
| July 8, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | A | Common Stock | 60000 | $0.00 | 158,189.0000 | 49,652,878 | 61.11% | 0.12% |
| July 9, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 32979 | $15.69 | 369,595.0000 | 49,652,878 | 8.19% | 0.07% |
| July 8, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Common Stock | 87500 | $0.00 | 402,574.0000 | 49,652,878 | 27.77% | 0.18% |
| June 6, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 322,243.0000 | 49,652,878 | 5.10% | 0.03% |
| June 6, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 171,876.0000 | 49,652,878 | 8.33% | 0.03% |
| June 9, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7169 | $14.50 | 315,074.0000 | 49,652,878 | 2.22% | 0.01% |
| May 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3125 | $0.00 | 100,115.0000 | 49,652,878 | 3.22% | 0.01% |
| May 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 60,000.0000 | 49,652,878 | 7.69% | 0.01% |
| May 23, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2146 | $11.31 | 113,026.0000 | 49,652,878 | 1.86% | 0.00% |
| May 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 115,172.0000 | 49,652,878 | 4.54% | 0.01% |
| May 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3125 | $0.00 | 37,500.0000 | 49,652,878 | 7.69% | 0.01% |
| May 23, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 1926 | $11.31 | 98,189.0000 | 49,652,878 | 1.92% | 0.00% |
| May 21, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 23250 | $0.00 | 348,750.0000 | 49,652,878 | 6.25% | 0.05% |
| May 21, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3750 | $0.00 | 56,250.0000 | 49,652,878 | 6.25% | 0.01% |
| May 21, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 23250 | $0.00 | 316,617.0000 | 49,652,878 | 7.93% | 0.05% |
| May 22, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 9999 | $11.88 | 306,618.0000 | 49,652,878 | 3.16% | 0.02% |
| May 21, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6250 | $0.00 | 112,861.0000 | 49,652,878 | 5.86% | 0.01% |
| May 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2689 | $11.88 | 110,172.0000 | 49,652,878 | 2.38% | 0.01% |
| May 21, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 93,750.0000 | 49,652,878 | 6.25% | 0.01% |
| May 21, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3750 | $0.00 | 99,307.0000 | 49,652,878 | 3.92% | 0.01% |
| May 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 2317 | $11.88 | 96,990.0000 | 49,652,878 | 2.33% | 0.00% |
| May 19, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2776 | $11.84 | 106,611.0000 | 49,652,878 | 2.54% | 0.01% |
| May 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 9,675.0000 | 49,652,878 | 20.00% | 0.00% |
| May 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 4205 | $0.00 | 98,157.0000 | 49,652,878 | 4.48% | 0.01% |
| May 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 8,056.0000 | 49,652,878 | 33.33% | 0.01% |
| May 19, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 2600 | $11.84 | 95,557.0000 | 49,652,878 | 2.65% | 0.01% |
| May 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 7,095.0000 | 49,652,878 | 20.00% | 0.00% |
| May 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 2431 | $0.00 | 4,861.0000 | 49,652,878 | 33.34% | 0.00% |
| May 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 9364 | $0.00 | 297,175.0000 | 49,652,878 | 3.25% | 0.02% |
| May 19, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 3808 | $11.84 | 293,367.0000 | 49,652,878 | 1.28% | 0.01% |
| May 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 9,675.0000 | 49,652,878 | 20.00% | 0.00% |
| May 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6945 | $0.00 | 13,889.0000 | 49,652,878 | 33.33% | 0.01% |
| May 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6447 | $0.00 | 109,387.0000 | 49,652,878 | 6.26% | 0.01% |
| April 9, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 25000 | $9.42 | 5,303,985.0000 | 46,590,154 | 0.47% | 0.05% |
| March 6, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 294,480.0000 | 46,590,154 | 5.60% | 0.03% |
| March 7, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 6669 | $11.97 | 287,811.0000 | 46,590,154 | 2.26% | 0.01% |
| March 6, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 187,501.0000 | 46,590,154 | 7.69% | 0.03% |
| Feb. 21, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 372000 | $0.00 | 372,000.0000 | 46,590,154 | 9999.99% | 0.80% |
| Feb. 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3125 | $0.00 | 95,870.0000 | 46,590,154 | 3.37% | 0.01% |
| Feb. 24, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 1918 | $10.02 | 93,952.0000 | 46,590,154 | 2.00% | 0.00% |
| Feb. 21, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | A | Restricted Stock Unit | 60000 | $0.00 | 60,000.0000 | 46,590,154 | 9999.99% | 0.13% |
| Feb. 22, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3125 | $0.00 | 40,625.0000 | 46,590,154 | 7.14% | 0.01% |
| Feb. 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 105,334.0000 | 46,590,154 | 4.98% | 0.01% |
| Feb. 21, 2025 | Piekos Brian | Chief Financial Officer | A | Restricted Stock Unit | 80000 | $0.00 | 80,000.0000 | 46,590,154 | 9999.99% | 0.17% |
| Feb. 24, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2394 | $10.02 | 102,940.0000 | 46,590,154 | 2.27% | 0.01% |
| Feb. 21, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 46,590,154 | 9999.99% | 0.21% |
| Feb. 22, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 65,000.0000 | 46,590,154 | 7.14% | 0.01% |
| Feb. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 12,094.0000 | 46,590,154 | 16.67% | 0.01% |
| Feb. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 4204 | $0.00 | 95,346.0000 | 46,590,154 | 4.61% | 0.01% |
| Feb. 18, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 2601 | $9.82 | 92,745.0000 | 46,590,154 | 2.73% | 0.01% |
| Feb. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 8,869.0000 | 46,590,154 | 16.67% | 0.00% |
| Feb. 17, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 2430 | $0.00 | 7,292.0000 | 46,590,154 | 24.99% | 0.01% |
| Feb. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6447 | $0.00 | 103,459.0000 | 46,590,154 | 6.65% | 0.01% |
| Feb. 18, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 3125 | $9.82 | 100,334.0000 | 46,590,154 | 3.02% | 0.01% |
| Feb. 17, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 12,084.0000 | 46,590,154 | 25.00% | 0.01% |
| Feb. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 9363 | $0.00 | 283,959.0000 | 46,590,154 | 3.41% | 0.02% |
| Feb. 18, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 5104 | $9.82 | 278,855.0000 | 46,590,154 | 1.80% | 0.01% |
| Feb. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 12,094.0000 | 46,590,154 | 16.67% | 0.01% |
| Feb. 17, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6944 | $0.00 | 20,834.0000 | 46,590,154 | 25.00% | 0.01% |
| Feb. 13, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 61700 | $9.33 | 5,278,985.0000 | 46,590,154 | 1.18% | 0.13% |
| Feb. 12, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 100000 | $9.23 | 5,217,285.0000 | 46,590,154 | 1.95% | 0.21% |
| Feb. 10, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 4137 | $9.14 | 5,090,582.0000 | 46,590,154 | 0.08% | 0.01% |
| Feb. 11, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 26703 | $9.18 | 5,117,285.0000 | 46,590,154 | 0.52% | 0.06% |
| Feb. 7, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 73649 | $9.29 | 5,086,445.0000 | 46,590,154 | 1.47% | 0.16% |
| Jan. 30, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 43707 | $8.76 | 4,986,480.0000 | 46,590,154 | 0.88% | 0.09% |
| Feb. 3, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 14562 | $9.22 | 5,012,796.0000 | 46,590,154 | 0.29% | 0.03% |
| Jan. 31, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 11754 | $8.89 | 4,998,234.0000 | 46,590,154 | 0.24% | 0.03% |
| Dec. 6, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 282,223.0000 | 46,590,154 | 5.86% | 0.03% |
| Dec. 9, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7627 | $9.75 | 274,596.0000 | 46,590,154 | 2.70% | 0.02% |
| Dec. 6, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 203,126.0000 | 46,590,154 | 7.14% | 0.03% |
| Nov. 22, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 70,000.0000 | 46,590,154 | 6.67% | 0.01% |
| Nov. 22, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 99,199.0000 | 46,590,154 | 5.31% | 0.01% |
| Nov. 26, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2187 | $9.87 | 97,012.0000 | 46,590,154 | 2.20% | 0.00% |
| Nov. 22, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3125 | $0.00 | 43,750.0000 | 46,590,154 | 6.67% | 0.01% |
| Nov. 22, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3125 | $0.00 | 93,105.0000 | 46,590,154 | 3.47% | 0.01% |
| Nov. 26, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 1963 | $9.87 | 91,142.0000 | 46,590,154 | 2.11% | 0.00% |
| Nov. 23, 2024 | Reid Laurence | Not found | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 46,590,154 | 9999.99% | 0.04% |
| Nov. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 18531 | $0.00 | 102,276.0000 | 46,590,154 | 22.13% | 0.04% |
| Nov. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12084 | $0.00 | 0.0000 | 46,590,154 | 100.00% | 0.03% |
| Nov. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 16,112.0000 | 46,590,154 | 20.00% | 0.01% |
| Nov. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 14,513.0000 | 46,590,154 | 14.29% | 0.01% |
| Nov. 18, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 8077 | $9.26 | 94,199.0000 | 46,590,154 | 7.90% | 0.02% |
| Nov. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Performance Stock Units | 7291 | $0.00 | 0.0000 | 46,590,154 | 100.00% | 0.02% |
| Nov. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 2431 | $0.00 | 9,722.0000 | 46,590,154 | 20.00% | 0.01% |
| Nov. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 10,643.0000 | 46,590,154 | 14.29% | 0.00% |
| Nov. 18, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 7192 | $9.26 | 89,980.0000 | 46,590,154 | 7.40% | 0.02% |
| Nov. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 11496 | $0.00 | 97,172.0000 | 46,590,154 | 13.42% | 0.02% |
| Nov. 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Performance Stock Units | 20834 | $0.00 | 0.0000 | 46,590,154 | 100.00% | 0.04% |
| Nov. 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6945 | $0.00 | 27,778.0000 | 46,590,154 | 20.00% | 0.01% |
| Nov. 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 14,513.0000 | 46,590,154 | 14.29% | 0.01% |
| Nov. 18, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 14400 | $9.26 | 266,598.0000 | 46,590,154 | 5.12% | 0.03% |
| Nov. 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 30198 | $0.00 | 280,998.0000 | 46,590,154 | 12.04% | 0.06% |
| Oct. 3, 2024 | Fairey William | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 46,590,154 | 9999.99% | 0.02% |
| Oct. 3, 2024 | Pereira Brian JG | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 46,590,154 | 9999.99% | 0.02% |
| Oct. 3, 2024 | Stuart Nancy | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 46,590,154 | 9999.99% | 0.02% |
| Oct. 3, 2024 | Treanor Patrick | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 46,590,154 | 9999.99% | 0.02% |
| Oct. 3, 2024 | Unkart Edward W | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 46,590,154 | 9999.99% | 0.02% |
| Sept. 9, 2024 | Piekos Brian | Chief Financial Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 36,786,575 | 9999.99% | 0.27% |
| Sept. 9, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7352 | $12.19 | 250,800.0000 | 36,786,575 | 2.85% | 0.02% |
| Sept. 6, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 258,152.0000 | 36,786,575 | 6.44% | 0.04% |
| Sept. 6, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 218,751.0000 | 36,786,575 | 6.67% | 0.04% |
| Aug. 23, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 1916 | $12.40 | 85,676.0000 | 36,786,575 | 2.19% | 0.01% |
| Aug. 22, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 85,880.0000 | 36,786,575 | 6.18% | 0.01% |
| Aug. 23, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2135 | $12.40 | 83,745.0000 | 36,786,575 | 2.49% | 0.01% |
| Aug. 22, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 75,000.0000 | 36,786,575 | 6.25% | 0.01% |
| Aug. 22, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 3125 | $0.00 | 87,592.0000 | 36,786,575 | 3.70% | 0.01% |
| Aug. 22, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 3125 | $0.00 | 46,875.0000 | 36,786,575 | 6.25% | 0.01% |
| Aug. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 2430 | $0.00 | 12,153.0000 | 36,786,575 | 16.66% | 0.01% |
| Aug. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 18528 | $0.00 | 88,853.0000 | 36,786,575 | 26.35% | 0.05% |
| Aug. 19, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 7973 | $12.01 | 80,880.0000 | 36,786,575 | 8.97% | 0.02% |
| Aug. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2418 | $0.00 | 16,932.0000 | 36,786,575 | 12.50% | 0.01% |
| Aug. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4027 | $0.00 | 20,140.0000 | 36,786,575 | 16.66% | 0.01% |
| Aug. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12083 | $0.00 | 12,084.0000 | 36,786,575 | 50.00% | 0.03% |
| Aug. 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 30195 | $0.00 | 256,742.0000 | 36,786,575 | 13.33% | 0.08% |
| Aug. 19, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 14215 | $12.01 | 242,527.0000 | 36,786,575 | 5.54% | 0.04% |
| Aug. 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2418 | $0.00 | 16,932.0000 | 36,786,575 | 12.50% | 0.01% |
| Aug. 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6944 | $0.00 | 34,723.0000 | 36,786,575 | 16.67% | 0.02% |
| Aug. 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Performance Stock Units | 20833 | $0.00 | 20,834.0000 | 36,786,575 | 50.00% | 0.06% |
| Aug. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 11495 | $0.00 | 91,569.0000 | 36,786,575 | 14.36% | 0.03% |
| Aug. 19, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 7102 | $12.01 | 84,467.0000 | 36,786,575 | 7.76% | 0.02% |
| Aug. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1773 | $0.00 | 12,417.0000 | 36,786,575 | 12.49% | 0.00% |
| Aug. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Performance Stock Units | 7292 | $0.00 | 7,291.0000 | 36,786,575 | 50.00% | 0.02% |
| June 6, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 15625 | $0.00 | 232,012.0000 | 36,786,575 | 7.22% | 0.04% |
| June 7, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7465 | $11.53 | 224,547.0000 | 36,786,575 | 3.22% | 0.02% |
| June 6, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 15625 | $0.00 | 234,375.0000 | 36,786,575 | 6.25% | 0.04% |
| May 22, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 80000 | $0.00 | 80,000.0000 | 36,786,575 | 9999.99% | 0.22% |
| May 22, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 36,786,575 | 9999.99% | 0.14% |
| May 20, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 8088 | $11.76 | 72,858.0000 | 36,786,575 | 9.99% | 0.02% |
| May 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 14,190.0000 | 36,786,575 | 11.11% | 0.00% |
| May 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 2431 | $0.00 | 14,583.0000 | 36,786,575 | 14.29% | 0.01% |
| May 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Performance Stock Units | 7292 | $0.00 | 0.0000 | 36,786,575 | 100.00% | 0.02% |
| May 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Performance Stock Units | 7292 | $0.00 | 14,583.0000 | 36,786,575 | 33.33% | 0.02% |
| May 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 30614 | $0.00 | 83,500.0000 | 36,786,575 | 57.89% | 0.08% |
| May 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6945 | $0.00 | 41,667.0000 | 36,786,575 | 14.29% | 0.02% |
| May 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 18789 | $0.00 | 80,946.0000 | 36,786,575 | 30.23% | 0.05% |
| May 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Performance Stock Units | 20834 | $0.00 | 0.0000 | 36,786,575 | 100.00% | 0.06% |
| May 20, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | S | Common Stock | 21959 | $11.76 | 216,387.0000 | 36,786,575 | 9.21% | 0.06% |
| May 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 19,350.0000 | 36,786,575 | 11.11% | 0.01% |
| May 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Performance Stock Units | 7292 | $0.00 | 14,583.0000 | 36,786,575 | 33.33% | 0.02% |
| May 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Performance Stock Units | 7292 | $0.00 | 0.0000 | 36,786,575 | 100.00% | 0.02% |
| May 20, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12083 | $0.00 | 24,167.0000 | 36,786,575 | 33.33% | 0.03% |
| May 20, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12084 | $0.00 | 0.0000 | 36,786,575 | 100.00% | 0.03% |
| May 20, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 24,167.0000 | 36,786,575 | 14.29% | 0.01% |
| May 20, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 19,350.0000 | 36,786,575 | 11.11% | 0.01% |
| May 20, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 13175 | $11.76 | 70,325.0000 | 36,786,575 | 15.78% | 0.04% |
| May 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 2431 | $0.00 | 14,583.0000 | 36,786,575 | 14.29% | 0.01% |
| May 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 14,190.0000 | 36,786,575 | 11.11% | 0.00% |
| May 20, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 11610 | $11.76 | 80,074.0000 | 36,786,575 | 12.66% | 0.03% |
| May 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 18789 | $0.00 | 91,684.0000 | 36,786,575 | 25.78% | 0.05% |
| May 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Common Stock | 51031 | $0.00 | 238,346.0000 | 36,786,575 | 27.24% | 0.14% |
| May 17, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | M | Performance Stock Units | 20833 | $0.00 | 41,667.0000 | 36,786,575 | 33.33% | 0.06% |
| April 18, 2024 | Fairey William | Not found | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 20, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Pre-Funded Warrants (Right to Buy) | 655738 | $15.25 | 655,738.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Common Stock | 18788 | $0.00 | 84,948.0000 | 0 | 28.40% | 0.00% |
| Feb. 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 18788 | $0.00 | 90,445.0000 | 0 | 26.22% | 0.00% |
| Feb. 20, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 8397 | $14.11 | 82,048.0000 | 0 | 9.28% | 0.00% |
| Feb. 20, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 19591 | $14.04 | 62,457.0000 | 0 | 23.88% | 0.00% |
| Feb. 20, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 300 | $14.72 | 62,157.0000 | 0 | 0.48% | 0.00% |
| Feb. 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 15,964.0000 | 0 | 10.00% | 0.00% |
| Feb. 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 2430 | $0.00 | 17,014.0000 | 0 | 12.50% | 0.00% |
| Feb. 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Performance Stock Units | 7292 | $0.00 | 7,292.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Performance Stock Units | 7292 | $0.00 | 21,875.0000 | 0 | 25.00% | 0.00% |
| Feb. 20, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 12053 | $14.11 | 72,895.0000 | 0 | 14.19% | 0.00% |
| Feb. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 15,964.0000 | 0 | 10.00% | 0.00% |
| Feb. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Restricted Stock Unit | 2430 | $0.00 | 17,014.0000 | 0 | 12.50% | 0.00% |
| Feb. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Performance Stock Units | 7292 | $0.00 | 7,292.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M | Performance Stock Units | 7292 | $0.00 | 29,167.0000 | 0 | 20.00% | 0.00% |
| Feb. 17, 2024 | Palleiko Benjamin L | CFO, CBO | M | Common Stock | 51029 | $0.00 | 210,117.0000 | 0 | 32.08% | 0.00% |
| Feb. 20, 2024 | Palleiko Benjamin L | CFO, CBO | S | Common Stock | 22802 | $14.11 | 187,315.0000 | 0 | 10.85% | 0.00% |
| Feb. 17, 2024 | Palleiko Benjamin L | CFO, CBO | M | Restricted Stock Unit | 2419 | $0.00 | 21,769.0000 | 0 | 10.00% | 0.00% |
| Feb. 17, 2024 | Palleiko Benjamin L | CFO, CBO | M | Restricted Stock Unit | 6944 | $0.00 | 48,612.0000 | 0 | 12.50% | 0.00% |
| Feb. 17, 2024 | Palleiko Benjamin L | CFO, CBO | M | Performance Stock Units | 20833 | $0.00 | 20,834.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | Palleiko Benjamin L | CFO, CBO | M | Performance Stock Units | 20833 | $0.00 | 62,500.0000 | 0 | 25.00% | 0.00% |
| Feb. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 30613 | $0.00 | 67,181.0000 | 0 | 83.72% | 0.00% |
| Feb. 20, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 14295 | $14.12 | 52,886.0000 | 0 | 21.28% | 0.00% |
| Feb. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 21,769.0000 | 0 | 10.00% | 0.00% |
| Feb. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 28,195.0000 | 0 | 12.50% | 0.00% |
| Feb. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12083 | $0.00 | 12,084.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12083 | $0.00 | 36,250.0000 | 0 | 25.00% | 0.00% |
| Feb. 17, 2024 | Crockett Thomas Andrew | CEO | M | Common Stock | 54415 | $0.00 | 236,091.0000 | 0 | 29.95% | 0.00% |
| Feb. 20, 2024 | Crockett Thomas Andrew | CEO | S | Common Stock | 24888 | $14.11 | 211,203.0000 | 0 | 10.54% | 0.00% |
| Feb. 17, 2024 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 52,245.0000 | 0 | 10.00% | 0.00% |
| Feb. 17, 2024 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6944 | $0.00 | 48,612.0000 | 0 | 12.50% | 0.00% |
| Feb. 17, 2024 | Crockett Thomas Andrew | CEO | M | Performance Stock Units | 20833 | $0.00 | 20,834.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | Crockett Thomas Andrew | CEO | M | Performance Stock Units | 20833 | $0.00 | 62,500.0000 | 0 | 25.00% | 0.00% |
| Feb. 14, 2024 | Palleiko Benjamin L | CFO, CBO | S | Common Stock | 40855 | $15.01 | 159,088.0000 | 0 | 20.43% | 0.00% |
| Feb. 14, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 39886 | $15.01 | 66,160.0000 | 0 | 37.61% | 0.00% |
| Feb. 14, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 28171 | $15.01 | 71,657.0000 | 0 | 28.22% | 0.00% |
| Feb. 14, 2024 | Crockett Thomas Andrew | CEO | S | Common Stock | 58356 | $15.01 | 181,676.0000 | 0 | 24.31% | 0.00% |
| Feb. 11, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | A | Performance Stock Units | 29167 | $0.00 | 29,167.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | A | Common Stock | 60000 | $0.00 | 106,046.0000 | 0 | 130.30% | 0.00% |
| Feb. 11, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | A | Performance Stock Units | 29167 | $0.00 | 29,167.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2024 | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 60000 | $0.00 | 99,828.0000 | 0 | 150.65% | 0.00% |
| Feb. 11, 2024 | Palleiko Benjamin L | CFO, CBO | A | Performance Stock Units | 83333 | $0.00 | 83,333.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2024 | Palleiko Benjamin L | CFO, CBO | A | Common Stock | 87500 | $0.00 | 199,943.0000 | 0 | 77.82% | 0.00% |
| Feb. 11, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | A | Performance Stock Units | 48333 | $0.00 | 48,333.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2024 | Crockett Thomas Andrew | CEO | A | Performance Stock Units | 83333 | $0.00 | 83,333.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2024 | Crockett Thomas Andrew | CEO | A | Common Stock | 122500 | $0.00 | 240,032.0000 | 0 | 104.23% | 0.00% |
| Feb. 7, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 51827 | $14.56 | 4,794,984.0000 | 0 | 1.09% | 0.00% |
| Feb. 8, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 29747 | $14.70 | 4,824,731.0000 | 0 | 0.62% | 0.00% |
| Feb. 6, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 4474 | $14.74 | 4,743,157.0000 | 0 | 0.09% | 0.00% |
| Feb. 1, 2024 | Crockett Thomas Andrew | CEO | S | Common Stock | 9300 | $16.18 | 118,232.0000 | 0 | 7.29% | 0.00% |
| Feb. 1, 2024 | Crockett Thomas Andrew | CEO | S | Common Stock | 700 | $16.81 | 117,532.0000 | 0 | 0.59% | 0.00% |
| Jan. 30, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 88099 | $14.47 | 4,738,683.0000 | 0 | 1.89% | 0.00% |
| Jan. 29, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 80600 | $14.22 | 4,650,584.0000 | 0 | 1.76% | 0.00% |
| Jan. 26, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 4174 | $12.98 | 4,569,984.0000 | 0 | 0.09% | 0.00% |
| Jan. 25, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 7030 | $12.73 | 4,565,810.0000 | 0 | 0.15% | 0.00% |
| Jan. 22, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 67546 | $12.55 | 4,527,197.0000 | 0 | 1.51% | 0.00% |
| Jan. 24, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 20686 | $12.44 | 4,558,780.0000 | 0 | 0.46% | 0.00% |
| Jan. 23, 2024 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 10897 | $12.54 | 4,538,094.0000 | 0 | 0.24% | 0.00% |
| Jan. 18, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 39680 | $12.51 | 4,434,651.0000 | 0 | 0.90% | 0.00% |
| Jan. 19, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 25000 | $12.43 | 4,459,651.0000 | 0 | 0.56% | 0.00% |
| Jan. 17, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 78925 | $12.60 | 4,394,971.0000 | 0 | 1.83% | 0.00% |
| Jan. 16, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 19599 | $12.73 | 4,316,046.0000 | 0 | 0.46% | 0.00% |
| Jan. 11, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 6647 | $12.68 | 4,296,447.0000 | 0 | 0.15% | 0.00% |
| Jan. 11, 2024 | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 22679 | $13.03 | 39,828.0000 | 0 | 36.28% | 0.00% |
| Jan. 9, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 20816 | $12.56 | 4,242,100.0000 | 0 | 0.49% | 0.00% |
| Jan. 10, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 47700 | $12.67 | 4,289,800.0000 | 0 | 1.12% | 0.00% |
| Jan. 8, 2024 | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 17221 | $13.01 | 62,607.0000 | 0 | 21.57% | 0.00% |
| Jan. 8, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 69184 | $12.44 | 4,221,284.0000 | 0 | 1.67% | 0.00% |
| Jan. 9, 2024 | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 100 | $13.00 | 62,507.0000 | 0 | 0.16% | 0.00% |
| Jan. 4, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 41764 | $12.11 | 4,152,100.0000 | 0 | 1.02% | 0.00% |
| Jan. 3, 2024 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 17605 | $12.20 | 4,110,336.0000 | 0 | 0.43% | 0.00% |
| Dec. 28, 2023 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 471490 | $12.50 | 4,086,718.0000 | 0 | 13.04% | 0.00% |
| Dec. 27, 2023 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 41514 | $11.97 | 3,615,228.0000 | 0 | 1.16% | 0.00% |
| Dec. 29, 2023 | Venrock Healthcare Capital Partners III, L.P. | TenPercentOwner | P | Common Stock | 6013 | $12.49 | 4,092,731.0000 | 0 | 0.15% | 0.00% |
| Dec. 27, 2023 | Crockett Thomas Andrew | CEO | S | Common Stock | 30000 | $12.02 | 127,532.0000 | 0 | 19.04% | 0.00% |
| Nov. 17, 2023 | Yea Christopher | Chief Development Officer | M | Restricted Stock Unit | 2431 | $0.00 | 19,444.0000 | 0 | 11.11% | 0.00% |
| Nov. 17, 2023 | Yea Christopher | Chief Development Officer | M | Restricted Stock Unit | 1774 | $0.00 | 17,738.0000 | 0 | 9.09% | 0.00% |
| Nov. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Common Stock | 30197 | $0.00 | 125,451.0000 | 0 | 31.70% | 0.00% |
| Nov. 20, 2023 | Audhya Paul K. | Chief Medical Officer | S | Common Stock | 7985 | $8.23 | 36,568.0000 | 0 | 17.92% | 0.00% |
| Nov. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 2419 | $0.00 | 24,188.0000 | 0 | 9.09% | 0.00% |
| Nov. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 4028 | $0.00 | 32,223.0000 | 0 | 11.11% | 0.00% |
| Nov. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Performance Stock Unit | 12083 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 20, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | S | Common Stock | 13008 | $8.23 | 112,443.0000 | 0 | 10.37% | 0.00% |
| Nov. 17, 2023 | Yea Christopher | Chief Development Officer | M | Performance Stock Unit | 7292 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 17, 2023 | Crockett Thomas Andrew | CEO | M | Performance Stock Unit | 20833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 17, 2023 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 58,050.0000 | 0 | 9.09% | 0.00% |
| Nov. 17, 2023 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6945 | $0.00 | 55,556.0000 | 0 | 11.11% | 0.00% |
| Nov. 20, 2023 | Crockett Thomas Andrew | CEO | S | Common Stock | 14807 | $8.23 | 157,532.0000 | 0 | 8.59% | 0.00% |
| Nov. 17, 2023 | Crockett Thomas Andrew | CEO | M | Common Stock | 33583 | $0.00 | 172,339.0000 | 0 | 24.20% | 0.00% |
| Nov. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Performance Stock Unit | 20833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 2419 | $0.00 | 24,188.0000 | 0 | 9.09% | 0.00% |
| Nov. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 6945 | $0.00 | 55,556.0000 | 0 | 11.11% | 0.00% |
| Nov. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Performance Stock Unit | 7292 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 17, 2023 | Yea Christopher | Chief Development Officer | M | Common Stock | 11497 | $0.00 | 53,159.0000 | 0 | 27.60% | 0.00% |
| Nov. 20, 2023 | Yea Christopher | Chief Development Officer | S | Common Stock | 7113 | $8.23 | 46,046.0000 | 0 | 13.38% | 0.00% |
| Nov. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 2431 | $0.00 | 19,444.0000 | 0 | 11.11% | 0.00% |
| Nov. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Common Stock | 11497 | $0.00 | 84,786.0000 | 0 | 15.69% | 0.00% |
| Nov. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 1774 | $0.00 | 17,738.0000 | 0 | 9.09% | 0.00% |
| Nov. 20, 2023 | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 4958 | $8.23 | 79,828.0000 | 0 | 5.85% | 0.00% |
| Nov. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Common Stock | 18530 | $0.00 | 44,553.0000 | 0 | 71.21% | 0.00% |
| Oct. 30, 2023 | Crockett Thomas Andrew | CEO | G | Common Stock | 8000 | $0.00 | 138,756.0000 | 0 | 5.45% | 0.00% |
| Sept. 26, 2023 | Pereira Brian JG | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 26, 2023 | Unkart Edward W | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 26, 2023 | Stuart Nancy | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 26, 2023 | Treanor Patrick | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 26, 2023 | Cha Albert | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | Cha Albert | Director | M | Common Stock | 6000 | $6.71 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | Cha Albert | Director | M | Common Stock | 12000 | $7.88 | 18,000.0000 | 0 | 200.00% | 0.00% |
| Sept. 11, 2023 | Cha Albert | Director | S | Common Stock | 18000 | $10.50 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 11, 2023 | Cha Albert | Director | M | Employee Stock Option (right to buy) | 6000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 11, 2023 | Cha Albert | Director | M | Employee Stock Option (right to buy) | 12000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | Crockett Thomas Andrew | CEO | M | Common Stock | 33582 | $0.00 | 161,632.0000 | 0 | 26.23% | 0.00% |
| Aug. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 2418 | $0.00 | 26,607.0000 | 0 | 8.33% | 0.00% |
| Aug. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 6944 | $0.00 | 62,501.0000 | 0 | 10.00% | 0.00% |
| Aug. 18, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | S | Common Stock | 13067 | $10.73 | 95,254.0000 | 0 | 12.06% | 0.00% |
| Aug. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Common Stock | 30195 | $0.00 | 108,321.0000 | 0 | 38.65% | 0.00% |
| Aug. 17, 2023 | Yea Christopher | Chief Development Officer | M | Performance Stock Unit | 7291 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | Yea Christopher | Chief Development Officer | M | Restricted Stock Unit | 2430 | $0.00 | 21,875.0000 | 0 | 10.00% | 0.00% |
| Aug. 17, 2023 | Yea Christopher | Chief Development Officer | M | Restricted Stock Unit | 1773 | $0.00 | 19,512.0000 | 0 | 8.33% | 0.00% |
| Aug. 18, 2023 | Yea Christopher | Chief Development Officer | S | Common Stock | 7142 | $10.73 | 41,662.0000 | 0 | 14.63% | 0.00% |
| Aug. 17, 2023 | Yea Christopher | Chief Development Officer | M | Common Stock | 11494 | $0.00 | 48,804.0000 | 0 | 30.81% | 0.00% |
| Aug. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Performance Stock Unit | 7291 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 2430 | $0.00 | 21,875.0000 | 0 | 10.00% | 0.00% |
| Aug. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 1773 | $0.00 | 19,512.0000 | 0 | 8.33% | 0.00% |
| Aug. 18, 2023 | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 4976 | $10.73 | 73,289.0000 | 0 | 6.36% | 0.00% |
| Aug. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Common Stock | 11494 | $0.00 | 78,265.0000 | 0 | 17.21% | 0.00% |
| Aug. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Performance Stock Unit | 12083 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 4028 | $0.00 | 36,251.0000 | 0 | 10.00% | 0.00% |
| Aug. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 2418 | $0.00 | 26,607.0000 | 0 | 8.33% | 0.00% |
| Aug. 18, 2023 | Audhya Paul K. | Chief Medical Officer | S | Common Stock | 8020 | $10.73 | 26,023.0000 | 0 | 23.56% | 0.00% |
| Aug. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Common Stock | 18529 | $0.00 | 34,043.0000 | 0 | 119.43% | 0.00% |
| Aug. 17, 2023 | Crockett Thomas Andrew | CEO | M | Performance Stock Unit | 20833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 63,855.0000 | 0 | 8.33% | 0.00% |
| Aug. 17, 2023 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6944 | $0.00 | 62,501.0000 | 0 | 10.00% | 0.00% |
| Aug. 18, 2023 | Crockett Thomas Andrew | CEO | S | Common Stock | 14876 | $10.73 | 146,756.0000 | 0 | 9.20% | 0.00% |
| Aug. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Performance Stock Unit | 20833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 18, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | A | Employee Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Yea Christopher | Chief Development Officer | M | Restricted Stock Unit | 2430 | $0.00 | 26,736.0000 | 0 | 8.33% | 0.00% |
| Feb. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 6944 | $0.00 | 76,390.0000 | 0 | 8.33% | 0.00% |
| Feb. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 2430 | $0.00 | 26,736.0000 | 0 | 8.33% | 0.00% |
| Feb. 17, 2023 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6944 | $0.00 | 76,390.0000 | 0 | 8.33% | 0.00% |
| Feb. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 4027 | $0.00 | 44,307.0000 | 0 | 8.33% | 0.00% |
| May 18, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | S | Common Stock | 4037 | $10.14 | 78,126.0000 | 0 | 4.91% | 0.00% |
| May 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 4028 | $0.00 | 40,279.0000 | 0 | 9.09% | 0.00% |
| Jan. 11, 2023 | Audhya Paul K. | Chief Medical Officer | A | Restricted Stock Unit | 48334 | $0.00 | 48,334.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Audhya Paul K. | Chief Medical Officer | S | Common Stock | 2780 | $10.14 | 13,014.0000 | 0 | 17.60% | 0.00% |
| May 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Common Stock | 6447 | $0.00 | 15,794.0000 | 0 | 68.97% | 0.00% |
| May 17, 2023 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 69,660.0000 | 0 | 7.69% | 0.00% |
| May 17, 2023 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6945 | $0.00 | 69,445.0000 | 0 | 9.09% | 0.00% |
| Jan. 11, 2023 | Crockett Thomas Andrew | CEO | A | Restricted Stock Unit | 83334 | $0.00 | 83,334.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Crockett Thomas Andrew | CEO | S | Common Stock | 5627 | $10.14 | 128,050.0000 | 0 | 4.21% | 0.00% |
| May 17, 2023 | Crockett Thomas Andrew | CEO | M | Common Stock | 12750 | $0.00 | 133,677.0000 | 0 | 10.54% | 0.00% |
| May 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 1774 | $0.00 | 21,285.0000 | 0 | 7.69% | 0.00% |
| May 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 2431 | $0.00 | 24,305.0000 | 0 | 9.09% | 0.00% |
| Jan. 11, 2023 | Feener Edward P. | Chief Scientific Officer | A | Restricted Stock Unit | 29166 | $0.00 | 29,166.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 1786 | $10.14 | 66,771.0000 | 0 | 2.61% | 0.00% |
| May 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Common Stock | 4205 | $0.00 | 68,557.0000 | 0 | 6.53% | 0.00% |
| May 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 2419 | $0.00 | 29,025.0000 | 0 | 7.69% | 0.00% |
| May 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 6945 | $0.00 | 69,445.0000 | 0 | 9.09% | 0.00% |
| Jan. 11, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | A | Restricted Stock Unit | 83334 | $0.00 | 83,334.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 2419 | $0.00 | 29,025.0000 | 0 | 7.69% | 0.00% |
| May 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Common Stock | 9364 | $0.00 | 82,163.0000 | 0 | 12.86% | 0.00% |
| May 17, 2023 | Yea Christopher | Chief Development Officer | M | Restricted Stock Unit | 1774 | $0.00 | 21,285.0000 | 0 | 7.69% | 0.00% |
| May 17, 2023 | Yea Christopher | Chief Development Officer | M | Restricted Stock Unit | 2431 | $0.00 | 24,305.0000 | 0 | 9.09% | 0.00% |
| Jan. 11, 2023 | Yea Christopher | Chief Development Officer | A | Restricted Stock Unit | 29166 | $0.00 | 29,166.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Yea Christopher | Chief Development Officer | S | Common Stock | 2604 | $10.14 | 37,310.0000 | 0 | 6.52% | 0.00% |
| May 17, 2023 | Yea Christopher | Chief Development Officer | M | Common Stock | 4205 | $0.00 | 39,914.0000 | 0 | 11.78% | 0.00% |
| Feb. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Common Stock | 6446 | $0.00 | 6,313.0000 | 0 | 0.00% | 0.00% |
| Feb. 17, 2023 | Audhya Paul K. | Chief Medical Officer | S | Common Stock | 3412 | $7.66 | 9,347.0000 | 0 | 26.74% | 0.00% |
| Feb. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Performance Restricted Stock Unit | 4027 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2023 | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 2419 | $0.00 | 31,444.0000 | 0 | 7.14% | 0.00% |
| Feb. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Common Stock | 4204 | $0.00 | 66,580.0000 | 0 | 6.74% | 0.00% |
| Feb. 17, 2023 | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 2228 | $7.66 | 64,352.0000 | 0 | 3.35% | 0.00% |
| Feb. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Performance Restricted Stock Unit | 2430 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2023 | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 1774 | $0.00 | 23,059.0000 | 0 | 7.14% | 0.00% |
| Feb. 17, 2023 | Yea Christopher | Chief Development Officer | M | Common Stock | 4204 | $0.00 | 38,436.0000 | 0 | 12.28% | 0.00% |
| Feb. 17, 2023 | Yea Christopher | Chief Development Officer | S | Common Stock | 2727 | $7.66 | 35,709.0000 | 0 | 7.09% | 0.00% |
| Feb. 17, 2023 | Yea Christopher | Chief Development Officer | M | Performance Restricted Stock Unit | 2430 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2023 | Yea Christopher | Chief Development Officer | M | Restricted Stock Unit | 1774 | $0.00 | 23,059.0000 | 0 | 7.14% | 0.00% |
| Feb. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Common Stock | 9363 | $0.00 | 77,753.0000 | 0 | 13.69% | 0.00% |
| Feb. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | S | Common Stock | 4954 | $7.66 | 72,799.0000 | 0 | 6.37% | 0.00% |
| Feb. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Performance Restricted Stock Unit | 6944 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2023 | Palleiko Benjamin L | President, CFO, CBO & Sec'y | M | Restricted Stock Unit | 2419 | $0.00 | 31,444.0000 | 0 | 7.14% | 0.00% |
| Feb. 17, 2023 | Crockett Thomas Andrew | CEO | M | Common Stock | 12749 | $0.00 | 127,627.0000 | 0 | 11.10% | 0.00% |
| Feb. 17, 2023 | Crockett Thomas Andrew | CEO | S | Common Stock | 6700 | $7.66 | 120,927.0000 | 0 | 5.25% | 0.00% |
| Feb. 17, 2023 | Crockett Thomas Andrew | CEO | M | Performance Restricted Stock Unit | 6944 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 17, 2023 | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 75,465.0000 | 0 | 7.14% | 0.00% |